• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腹腔盆腔内细胞角蛋白(泛)阳性的EWSR1/FUS::CREB融合恶性肿瘤:4例临床病理及分子分析]

[Cytokeratin (pan)-positive EWSR1/FUS::CREB fusion malignant tumor in abdominopelvic cavity: a clinicopathological and molecular analysis of four cases].

作者信息

Zang F L, Wang Y, Wei X Y, Wang Y L, Luo Y, Guo Y H, Ding T T

机构信息

Department of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Tianjin Key Laboratory of Digestive Cancer, Tianjin 300060, China.

Public Laboratory, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Tianjin Key Laboratory of Digestive Cancer, Tianjin 300060, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2025 Jun 8;54(6):626-631. doi: 10.3760/cma.j.cn112151-20241116-00760.

DOI:10.3760/cma.j.cn112151-20241116-00760
PMID:40494767
Abstract

To investigate the clinicopathological and molecular genetic characteristics of pan cytokeratin (CKpan)-positive EWSR1/FUS::CREB fusion malignant tumors in abdominopelvic cavity. Four cases of malignant tumor with CKpan-positive EWSR1/FUS::CREB fusion were selected from January 2019 to July 2024 in the Department of Pathology, Tianjin Medical University Cancer Hospital, Tianjin, China. Their clinical, pathological, and immunohistochemical characteristics were examined. Their molecular genetic characteristics were analyzed using fluorescence in situ hybridization (FISH) and next-generation sequencing (NGS). Among the 4 patients, there were 2 males and 2 females, aged 44, 44, 48 and 66 years, respectively. The tumor sites included 1 case located between the stomach and transverse colon, 1 case on the serous surface of the gastric wall, 1 case in the transverse mesocolon, and 1 case in transverse mesocolon and small mesentery. The clinical manifestations were mostly abdominal distension and abdominal pain. The maximum diameter of the tumor in the surgical resection specimen was 3.5-8.5 cm. The tumor's cut surface was grayish-white and gray-yellow in color, with medium consistency. Microscopically, the tumor cells were mainly composed of epithelioid tumor cells, and 2 of the tumors showed that tumor cells arranged in a solid sheet or multinodular pattern, and the cytoplasm of the tumor cells was abundant, lightly stained, and the boundaries were unclear, accompanied by the formation of capsules or microcapsules, and lymphocyte and plasma cell sleeves were seen. In one case, the pseudopapillary arrangement was present, and the tumor cells were radially distributed around the fibrovascular axis. In another case, it was arranged in a pseudoacinar pattern, and the nest was surrounded by slender reticular fibers. Immunohistochemistry showed that tumor cells expressed CKpan (4/4) and WT1 (4/4, including 1 focal positive). Vimentin, CK8/18, D2-40 and S-100 were expressed in various intensities, while Calretinin was locally positive or negative. FISH showed that 2 cases had EWSR1 break-apart and 2 cases had FUS break-apart. NGS confirmed the presence of EWSR1::CREM fusion (1 case) and FUS::CREM fusion (2 cases), respectively. Except for 1 recently diagnosed case, 3 cases were followed up: 1 patient died due to tumor recurrence and metastasis (overall survival was 33 months), and 2 patients survived (1 case had recurrence 58 months after surgery, and 1 case had no recurrence or metastasis after surgery). CKpan-positive EWSR1/FUS::CREB fusion malignant tumor is a rare malignancy tumor with undetermined classification that tends to occur in the abdominopelvic cavity and often involves the gastrointestinal tract. Molecular testing such as FISH and NGS is helpful for a definitive diagnosis.

摘要

探讨全细胞角蛋白(CKpan)阳性的EWSR1/FUS::CREB融合性腹腔盆腔恶性肿瘤的临床病理及分子遗传学特征。选取2019年1月至2024年7月在中国天津医科大学肿瘤医院病理科确诊的4例CKpan阳性的EWSR1/FUS::CREB融合性恶性肿瘤病例,对其临床、病理及免疫组化特征进行观察,并采用荧光原位杂交(FISH)和二代测序(NGS)技术分析其分子遗传学特征。4例患者中,男性2例,女性2例,年龄分别为44岁、44岁、48岁和66岁。肿瘤位于胃与横结肠之间1例,胃壁浆膜面1例,横结肠系膜1例,横结肠系膜及小肠系膜1例。临床表现主要为腹胀和腹痛。手术切除标本中肿瘤最大径为3.5~8.5 cm。肿瘤切面呈灰白色和灰黄色,质地中等。镜下,肿瘤细胞主要由上皮样肿瘤细胞组成,其中2例肿瘤细胞呈实性片状或多结节状排列,肿瘤细胞胞质丰富,淡染,边界不清,可见包膜或微囊形成,伴淋巴细胞和浆细胞套。1例呈假乳头样排列,肿瘤细胞围绕纤维血管轴心呈放射状分布。另1例呈假腺泡样排列,巢团被纤细的网状纤维包绕。免疫组化显示肿瘤细胞表达CKpan(4/4)和WT1(4/4,其中1例局灶阳性)。波形蛋白、CK8/18、D2-40和S-100呈不同程度表达,钙视网膜蛋白局部阳性或阴性。FISH检测显示2例存在EWSR1基因断裂,2例存在FUS基因断裂。NGS分别证实1例存在EWSR1::CREM融合,另2例存在FUS::CREM融合。除1例近期确诊病例外,对3例进行随访:1例患者因肿瘤复发转移死亡(总生存33个月),2例存活(1例术后58个月复发,1例术后无复发转移)。CKpan阳性的EWSR1/FUS::CREB融合性恶性肿瘤是一种罕见的、分类未明的恶性肿瘤,好发于腹腔盆腔,常累及胃肠道。FISH和NGS等分子检测有助于明确诊断。

相似文献

1
[Cytokeratin (pan)-positive EWSR1/FUS::CREB fusion malignant tumor in abdominopelvic cavity: a clinicopathological and molecular analysis of four cases].[腹腔盆腔内细胞角蛋白(泛)阳性的EWSR1/FUS::CREB融合恶性肿瘤:4例临床病理及分子分析]
Zhonghua Bing Li Xue Za Zhi. 2025 Jun 8;54(6):626-631. doi: 10.3760/cma.j.cn112151-20241116-00760.
2
Clinicopathological and molecular characterization of astrocytoma.星形细胞瘤的临床病理及分子特征
Front Mol Neurosci. 2025 Feb 3;18:1483833. doi: 10.3389/fnmol.2025.1483833. eCollection 2025.
3
Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor.FET::CREB 融合阳性颅内间质瘤的潜在预后决定因素。
Acta Neuropathol Commun. 2024 Jan 30;12(1):17. doi: 10.1186/s40478-024-01721-2.
4
Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases.腹腔中 CK 阳性的伴 EWSR1/FUS-CREB 融合的恶性肿瘤:8 例临床病理研究。
Am J Surg Pathol. 2022 Jan 1;46(1):134-146. doi: 10.1097/PAS.0000000000001742.
5
Primary cutaneous rhabdomyosarcoma with EWSR1/FUS::TFCP2 fusion: four new cases with distinctive morphology, immunophenotypic, and genetic profile.伴有EWSR1/FUS::TFCP2融合的原发性皮肤横纹肌肉瘤:4例具有独特形态学、免疫表型和基因特征的新病例
Virchows Arch. 2024 Dec 18. doi: 10.1007/s00428-024-04007-z.
6
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
7
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.